Literature DB >> 29976121

Normative performance of healthy older individuals on the Modified Mini-Mental State (3MS) examination according to ethno-racial group, gender, age, and education level.

Joanne Ryan1, Robyn L Woods1, Carlene Britt1, Anne M Murray2,3, Raj C Shah4, Christopher M Reid1,5, Brenda Kirpach2, Rory S Wolfe1, Mark R Nelson1,6, Jessica E Lockery1, Suzanne G Orchard1, Ruth E Trevaks1, John J McNeil1, Elsdon Storey1.   

Abstract

OBJECTIVE: To present normative performance data on the Modified Mini-Mental State (3MS) examination for healthy community-dwelling older individuals according to gender, age, education level, and ethno-racial group.
METHOD: More than 19,000 generally healthy older men and women without a diagnosis of dementia were recruited from the general population in Australia and the U.S. for the ASPirin in Reducing Events in the Elderly (ASPREE) study. The 3MS exam was administered as part of the baseline screening and individuals scoring above 77 were eligible to participate.
RESULTS: The sample comprised 16,360 Australian whites, 1080 U.S. whites, 895 African-Americans and 316 Hispanic/Latinos. The median age of participants was 74 years (range 65-98), with an average of 12 years of education and 56% were female. Increasing age and fewer years of completed education were associated with lower scores on the 3MS. Women scored higher than men in most age and education categories. Differences across ethno-racial groups were found. With factor analysis, four factors were identified which accounted for 35% of the between-person variance in 3MS scores for white Australians.
CONCLUSIONS: This large cohort of older individuals provides some of the most comprehensive 3MS normative data to be generated for whites (Australian and U.S.), Hispanic/Latinos and African-Americans, by age, gender, and educational attainment. These findings will serve as important reference standards for monitoring cognitive function in generally healthy older individuals, becoming increasingly important as this fraction of the population increases.

Entities:  

Keywords:  Modified Mini-Mental Status examination (3MS); Word; aging; cognition; dementia; normative data

Year:  2018        PMID: 29976121      PMCID: PMC6810645          DOI: 10.1080/13854046.2018.1488996

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  24 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  3MS normative data for elderly African Americans.

Authors:  Lisa M Brown; John A Schinka; James A Mortimer; Amy Borenstein Graves
Journal:  J Clin Exp Neuropsychol       Date:  2003-04       Impact factor: 2.475

3.  3MS normative data for the elderly.

Authors:  Tatyana G Jones; John A Schinka; Rodney D Vanderploeg; Brent J Small; Amy Borenstein Graves; James A Mortimer
Journal:  Arch Clin Neuropsychol       Date:  2002-02       Impact factor: 2.813

4.  Sample Size in Factor Analysis: The Role of Model Error.

Authors:  R C MacCallum; K F Widaman; K J Preacher; S Hong
Journal:  Multivariate Behav Res       Date:  2001-10-01       Impact factor: 5.923

Review 5.  A review of screening tests for cognitive impairment.

Authors:  Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

6.  Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS.

Authors:  Tom N Tombaugh
Journal:  Arch Clin Neuropsychol       Date:  2005-06       Impact factor: 2.813

7.  An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the cache county study.

Authors:  JoAnn T Tschanz; Kathleen A Welsh-Bohmer; Brenda L Plassman; Maria C Norton; Bonita W Wyse; John C S Breitner
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2002-03

8.  Baseline experience with Modified Mini Mental State Exam: The Women's Health Initiative Memory Study (WHIMS).

Authors:  S R Rapp; M A Espeland; P Hogan; B N Jones; E Dugan
Journal:  Aging Ment Health       Date:  2003-05       Impact factor: 3.658

9.  IPA survey of brief cognitive screening instruments.

Authors:  Kenneth I Shulman; Nathan Herrmann; Henry Brodaty; Helen Chiu; Brian Lawlor; Karen Ritchie; James M Scanlan
Journal:  Int Psychogeriatr       Date:  2006-02-08       Impact factor: 3.878

10.  Limitations of the Mini-Mental State Examination.

Authors:  R I Naugle; K Kawczak
Journal:  Cleve Clin J Med       Date:  1989-05       Impact factor: 2.321

View more
  14 in total

1.  DNA methylation analysis of candidate genes associated with dementia in peripheral blood.

Authors:  Peter D Fransquet; Paul Lacaze; Richard Saffery; James Phung; Emily Parker; Raj C Shah; Anne Murray; Robyn L Woods; Joanne Ryan
Journal:  Epigenomics       Date:  2020-12-10       Impact factor: 4.778

2.  Anticholinergic medication burden and cognitive function in participants of the ASPREE study.

Authors:  Jonathan C Broder; Joanne Ryan; Raj C Shah; Jessica E Lockery; Suzanne G Orchard; Julia F-M Gilmartin-Thomas; Michelle A Fravel; Alice J Owen; Robyn L Woods; Rory Wolfe; Elsdon Storey; Anne M Murray; Michael E Ernst
Journal:  Pharmacotherapy       Date:  2021-12-14       Impact factor: 4.705

3.  Brain-predicted age difference is associated with cognitive processing in later-life.

Authors:  Jo Wrigglesworth; Nurathifah Yaacob; Phillip Ward; Robyn L Woods; John McNeil; Elsdon Storey; Gary Egan; Anne Murray; Raj C Shah; Sharna D Jamadar; Ruth Trevaks; Stephanie Ward; Ian H Harding; Joanne Ryan
Journal:  Neurobiol Aging       Date:  2021-10-20       Impact factor: 4.673

4.  Social isolation, social support, and loneliness and their relationship with cognitive health and dementia.

Authors:  Johanna Joyce; Joanne Ryan; Alice Owen; Jessie Hu; Joanna McHugh Power; Raj Shah; Robyn Woods; Elsdon Storey; Carlene Britt; Rosanne Freak-Poli
Journal:  Int J Geriatr Psychiatry       Date:  2021-11-05       Impact factor: 3.850

5.  Test-Retest Reliability and Minimal Detectable Change of Four Cognitive Tests in Community-Dwelling Older Adults.

Authors:  Katherine L Webb; Joanne Ryan; Rory Wolfe; Robyn L Woods; Raj C Shah; Anne M Murray; Suzanne G Orchard; Elsdon Storey
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

6.  The Utility of Assessing Health-Related Quality of Life to Predict Cognitive Decline and Dementia.

Authors:  Aung Zaw Zaw Phyo; David A Gonzalez-Chica; Nigel P Stocks; Elsdon Storey; Robyn L Woods; Anne M Murray; Suzanne G Orchard; Raj C Shah; Danijela Gasevic; Rosanne Freak-Poli; Joanne Ryan
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

7.  Accelerated Epigenetic Aging in Peripheral Blood does not Predict Dementia Risk.

Authors:  P D Fransquet; P Lacaze; R Saffery; R C Shah; R Vryer; A Murray; R L Woods; J Ryan
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

8.  A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults.

Authors:  Jessica E Lockery; Jonathan C Broder; Joanne Ryan; Ashley C Stewart; Robyn L Woods; Trevor T-J Chong; Geoffrey C Cloud; Anne Murray; Jason D Rigby; Raj Shah; Elsdon Storey; Stephanie A Ward; Rory Wolfe; Christopher M Reid; Taya A Collyer; Michael E Ernst
Journal:  J Gen Intern Med       Date:  2021-03-22       Impact factor: 6.473

9.  Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival.

Authors:  Joanne Ryan; Sara Espinoza; Michael E Ernst; A R M Saifuddin Ekram; Rory Wolfe; Anne M Murray; Raj C Shah; Suzanne G Orchard; Sharyn Fitzgerald; Lawrence J Beilin; Stephanie A Ward; Jeff D Williamson; Anne B Newman; John J McNeil; Robyn L Woods
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-01-07       Impact factor: 6.591

10.  Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.

Authors:  Joanne Ryan; Elsdon Storey; Anne M Murray; Robyn L Woods; Rory Wolfe; Christopher M Reid; Mark R Nelson; Trevor T J Chong; Jeff D Williamson; Stephanie A Ward; Jessica E Lockery; Suzanne G Orchard; Ruth Trevaks; Brenda Kirpach; Anne B Newman; Michael E Ernst; John J McNeil; Raj C Shah
Journal:  Neurology       Date:  2020-03-25       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.